基本信息
浏览量:192
职业迁徙
个人简介
Dr. Peter Schwartz has been a member of the Yale Cancer Center since he joined the Yale School of Medicine Faculty in 1975. He was the first Director of the Division of Gynecologic Oncology, which he formed in 1978, and the first Director of the Gynecologic Oncology Fellowship Training Program, which was approved by the American Board of Obstetrics and Gynecology, Division of Gynecologic Oncology in 1980. Dr. Schwartz has served as President of the New Haven Obstetrical Society, The New England Association of Gynecologic Oncologists, The Felix Rutledge Society and The Society for Gynecologic Oncology.His research has focused on gynecologic cancers and their treatment. He is recognized as an international expert on the management of the rare germ cell malignancies, as well as introducing neoadjuvant chemotherapy into the treatment of the common advanced stage epithelial ovarian cancers which now has been accepted as a standard treatment by the National Comprehensive Cancer Network for the United States. He performed the first prospective randomized trial incorporating hormonal therapy with conventional platinum-based chemotherapy based on laboratory research at Yale identifying estrogen receptor proteins in epithelial ovarian cancers. He reported the first series of gynecologic cancer patients to have massive hemorrhage controlled by selective arteriography and transcatheter embolization, coil placement or balloon catheter placement and subsequently showed these techniques could also be employed to control massive postpartum hemorrhage. His clinical studies on the management of uterine serous cancer established a very successful standard therapy for early stage disease, which previously had been associated with an extremely poor prognosis. He has had a strong interest in the early detection of ovarian cancer and established the Yale Early Detection Program for Ovarian Cancer in 1990, one of the first such programs in the United States. That program was based on prior tumor marker research and diagnostic imaging studies he performed with other collaborators at Yale. Dr. Schwartz is a member of the editorial boards of seven professional journals, has served on numerous Department and Yale Cancer Center committees and currently serves as a member of the Oncology Patient Safety and Quality Council and the Smilow Leadership Council.
研究兴趣
论文共 491 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Heart Rhythmno. 5 (2024): S297
Lia Crotti,Raquel A. Neves,Federica Dagradi, Giulia Musu, Federica Giannetti,Johan M. Bos, Miriam Barbieri, Paolo Cerea, Fulvio Giovenzana,Margherita Torchio,Manuela Mura,Massimiliano Gnecchi,
Heart Rhythmno. 5 (2024): S33
Christian Krijger Juárez, Virginnio Proost,Michael Tanck,Johan M. Bos,Raquel A. Neves,Lia Crotti,Julien Barc, Aurelien Cledel,Aurelie Thollet,Sven Dittmann, Corinna Rickert,Eric Schulze-Bahr,
Heart Rhythmno. 5 (2024): S296-S297
Cancer Researchno. 7_Supplement (2023): 3402-3402
引用0浏览0引用
0
0
CANCER MEDICINEno. 14 (2023): 15492-15503
A AlAshqar, L Mutlu, B McNamara, J Harold, M Clark, G Huang, M Azodi,PE Schwartz, A Santin, E Ratner, G Altwerger, V Andikyan
Journal of Minimally Invasive Gynecologyno. 11 (2023): S36
引用0浏览0引用
0
0
Levent Mutlu,Diego D. Manavella,Stefania Bellone,Blair Mcnamara, Justin A. Harold,Dennis Mauricio,Eric R. Siegel,Natalia Buza,Pei Hui, Tobias Max Philipp Hartwich,Yang Yang-Hartwich,Cem Demirkiran,
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn